Today, the FDA updated the shortage status for Tirzepatide and officially change the 10mg / 12.5mg / 15mg doses from "available" to "Intermittent back orders until end of July 2023".
Follow the FDA Tirzepatide shortage here: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st=c
Comments